#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endometrial cancer Multifocal motor neuropathy Thrombocytopenia Splenic marginal zone lymphoma Waldenstrom's macroglobulinaemia Prostate cancer Neuroendocrine carcinoma Amyotrophic lateral sclerosis gene carrier Extranodal marginal zone B-cell lymphoma (MALT type) Cervix carcinoma Cutaneous T-cell lymphoma stage II Cystic fibrosis lung Mitochondrial myopathy Guillain-Barre syndrome HER2 gene amplification More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome – Diagnostics Synovial sarcoma metastatic – Diagnostics Optic glioma – Diagnostics Mucous membrane pemphigoid – Treatment Wiskott-Aldrich syndrome – Trials in Disease Marginal zone lymphoma – Diagnostics Amyotrophic lateral sclerosis – Basic Information Cystic fibrosis – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Inclusion body myositis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cisatracurium Besilate Mitoxantrone A52 Anselamimab Glucose Monohydrate Ph. Eur. VHB937 Odronextamab Sitravatinib Malate Galunisertib Favezelimab Sotagliflozin Rugonersen ZILEBESIRAN Tolebrutinib Quercetin Calcium Folinate Censavudine Macrogol 3350 Bempikibart RIVASTIGMINE More therapies…

    Learn about Your Condition

    Metastatic glioma Benign neoplasm of ureter Breast cancer stage II Morning sickness Pulmonary venous thrombosis Von Hippel-Lindau disease Anal cancer Mixed-type liposarcoma Infertility male Apheresis Coagulopathy Toxicity to various agents Craniosynostosis Anal abscess Autoimmune haemolytic anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Tarlatamab
    France Greece Italy Spain

  • A study to evaluate the use of leflutrozole to improve semen quality in men with non-obstructive azoospermia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Infertility male
    Denmark

  • A study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tinlarebant
    Belgium France The Netherlands

  • A study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Etoposide
    France Germany Italy Spain

  • A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • VOROLANIB
    • Aflibercept
    Germany Poland Slovakia

  • A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Osteoarthritis
    • Overweight
    Bulgaria Denmark Greece Italy Poland Spain
Previous Page
1 … 32 33 34 35 36 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!